logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
F

Florian Lordick

University of Leipzig Medical Center
H指数:91
被引数:4.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Zolbetuximab plus chemotherapy versus immune checkpoint inhibitor regimens by programmed death-ligand 1 combined positive score in locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma: a Bayesian network meta-analysis

Zolbetuximab联合化疗与程序性死亡配体1联合阳性评分下免疫检查点抑制剂方案在局部晚期或转移性胃或胃食管结合部腺癌中的比较：一项贝叶斯网络Meta分析

ESMO Open
IF8.3
2026-09-010
OAAI
Shitara, K.; Rha, S. Y.; Klempner, S. J.; Lordick, F.; Ranganath, R.; Oh, M.; Getzenberg, R. H.; Gourgioti, G.; Chai, X.; Yang, H.
Older adults with resectable gastric cancer undergoing perioperative chemotherapy or preoperative chemoradiotherapy plus perioperative chemotherapy: A secondary analysis of the AGITG TOPGEAR phase III trial

可切除胃癌老年患者接受围手术期化疗或术前放化疗加围手术期化疗：AGITG TOPGEAR III期试验的二次分析

European Journal of Cancer
IF7.1
2026-08-010
PRE
Ruehle, Alexander; Krause, Alina; O'Connell, Rachel L.; Simes, John; Michael, Michael; Smithers, Bernard Mark; Wong, Rebecca K. S.; Haustermans, Karin; Nicolay, Nils H.; Leong, Trevor; Lordick, Florian
EORTC-1607-GITCG/ABC-09: Open-label first-line, single-arm phase II study of CisGem combined with pembrolizumab in patients with advanced or metastatic biliary tract cancer

EORTC-1607-GITCG/ABC-09：西吉姆联合帕博利珠单抗治疗晚期或转移性胆道癌的开放标签、单臂II期首线研究

Translational Oncology
IF4.1
2026-08-010
PRE
Lamarca, Angela; Maderer, Annett; Wagner, Daniel C.; McNamara, Mairead G.; Bridgewater, John A.; Arora, Arvind; Macarulla, Teresa; Adeva, Jorge; Hubner, Richard A.; Lordick, Florian; Foerster, Friedrich; Weinmann, Arndt; Galle, Peter R.; Leurquin, Bryan; Marreaud, Sandrine I.; Mauer, Murielle E.; Valle, Juan W.; Moehler, Markus
Efficacy and Descriptive Safety Assessment of Programmed Cell Death Protein-(Ligand) 1 Inhibitors Plus Chemotherapy as First-Line Treatment for Gastric and Gastroesophageal Junction Cancer in Asian and Non-Asian Patients: A Meta-Analysis

亚洲和非亚洲患者中程序性细胞死亡蛋白-(配体)1抑制剂联合化疗作为胃癌和胃食管结合部癌一线治疗的疗效和安全性描述性评估：一项Meta分析

Gastro Hep Advances
IF0
2026-01-010
OAAI
Lordick, Florian; Dotan, Efrat; Zhan, Lin; Zhang, Xiaowei; Barzi, Afsaneh; Ghali, Nadeem; Lee, Keun-Wook; Klempner, Samuel J.; Strickland, Matthew R.; Lonardi, Sara; Satoh, Taroh
Progression-Free Survival as a surrogate for Overall Survival in gastro-esophageal cancer trials with immunotherapy: a meta-analysis

无进展生存期作为免疫治疗在胃肠癌临床试验中总体生存期的替代指标：一项荟萃分析

European Journal of Cancer
IF7.1
2025-11-290
OAAI
Alberto Giovanni Leone; Fausto Petrelli; Samuel J. Klempner; Elizabeth C. Smyth; Raghav Sundar; Florian Lordick; Sylvie Lorenzen; Micheal Masetti; Radka Obermannova; Maria Alsina; Yelena Y Janjigian; Filippo Pietrantonio
Evolving treatment strategies for resectable gastric cancer: Bridging Asia-West disparities toward personalized and integrated therapy

可切除胃癌的治疗策略演变：弥合亚西方差异，迈向个体化与整合治疗

Cancer Treatment Reviews
IF10.5
2025-10-240
OAAI
Xuesong Zhao; Qianyun Hao; Maria Alsina; Daniel Acosta; Florian Castet; Eduardo Terán; Kreina Vega Cano; Tamara Saurí; Ismael Macías; Takaki Yoshikawa; Sandra Castro; Hirokazu Shoji; Florian Lordick; Zhanlong Shen; Tian V. Tian; Teresa Macarulla
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors

ESMO-ESTRO关于将放射疗法与免疫检查点抑制剂、VEGF(R)抑制剂或多靶点酪氨酸激酶抑制剂联合使用的安全性共识声明

Annals of Oncology
IF65.4
2025-09-260
PRE
E.S.M. van Aken; B. Devnani; A. Prelaj; L. Castelo-Branco; C.A.M. Marijnen; D. Martins-Branco; M.A. Gambacorta; A. Lamarca; K. Harrington; G. Minniti; M. Hecht; D. Papamichael; M. Krause; R. Cathomas; K. Lindberg; S.M. O’Cathail; U. Nestle; J. Barriuso; S. Nowicki; C. Rödel; P. Boot; C. Belka; U. Ricardi; F. Lordick; D. De Ruysscher; G. Pentheroudakis; M.C. de Jong; A.K. Gandhi
Early Cancer Survivorship Distress Trajectories Associated With Socioeconomic Status and Age: Findings From a Multicenter Prospective Study

与经济地位和年龄相关的早期癌症幸存者压力轨迹：一项多中心前瞻性研究的发现

Cancer Medicine
IF3.1
2025-08-010
OAAI
Anja Mehnert-Theuerkauf; Ute Goerling; Tanja Zimmermann; Jochen Ernst; Myriel Hermann; Beate Hornemann; Ulrich Keilholz; Florian Lordick; Olaf von dem Knesebeck; David Kissane; Anne-Kathrin Köditz; Franziska Springer
ESMO-ESTRO framework for assessing the interactions and safety of combining radiotherapy with targeted cancer therapies or immunotherapy

ESMO-ESTRO评估放射治疗与靶向癌症治疗或免疫治疗联合应用相互作用及安全性的框架

RADIOTHERAPY AND ONCOLOGY
IF5.3
2025-07-010
PRE
van Aken, Evert S. M.; Devnani, Bharti; Castelo-Branco, Luis; De Ruysscher, Dirk; Martins-Branco, Diogo; Marijnen, Corrie A. M.; Muoio, Barbara; Belka, Claus; Lordick, Florian; Kroeze, Stephanie; Pentheroudakis, George; Trapani, Dario; Ricardi, Umberto; Gandhi, Ajeet Kumar; Prelaj, Arsela; O'Cathail, Sean M.; de Jong, Monique C.

研究方向

暂未获取到该数据
E
Eric Van Cutsem
H 指数:174论文数:1,832被引数:17.4万
K
Katja Ott
H 指数:49论文数:221被引数:1.0万
S
Sylvie Lorenzen
H 指数:37论文数:379被引数:6,200
K
Kohei Shitara
H 指数:79论文数:1,129被引数:3.5万
M
Markus Moehler
H 指数:65论文数:710被引数:2.5万
E
Elizabeth Smyth
H 指数:44论文数:293被引数:1.9万
A
Andrés Cervantes
H 指数:99论文数:1,158被引数:6.1万
R
Radka Obermannová
H 指数:29论文数:121被引数:5,800
K
Karin Haustermans
H 指数:82论文数:899被引数:3.4万
I
Ines Gockel
H 指数:55论文数:684被引数:1.1万